Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis

Hsin Yi Yang, Ya Hui Tzeng, Chiah Yang Chai, An Tsz Hsieh, Jiun-Rong Chen, Le Shin Chang, Sien Sing Yang

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective: Non-alcoholic steatohepatitis (NASH) is a common cause of liver disease, and it may progress to fibrosis or cirrhosis. The aim of this study was to investigate the effects of soy protein on hepatic steatosis and insulin resistance in NASH. Methods: Forty male Sprague-Dawley rats were fed a high-fat diet for 4 wk to induce NASH and then were allocated to one of four diets: a NASH-inducing diet, a standard diet, a NASH-inducing diet plus soy protein, and a standard diet plus soy protein. Results: After the 10-wk experimental period, the results showed that soy protein significantly lowered plasma cholesterol concentrations and body fat accumulation. Soy protein intake also decreased the hepatic lipid depots of triacylglycerols and cholesterol and decreased the concentrations of lipid peroxides. In an analysis of antioxidative status, rats fed the soy protein diet showed improved antioxidative potential due to increases in superoxide dismutase and catalase activities and a decrease in the protein expression of cytochrome P450 2E1. Conclusion: Soy protein may improve the liver function in patients with NASH by lowering lipid levels in the blood and liver, increasing the antioxidative capacity, and improving insulin resistance.

Original languageEnglish
Pages (from-to)943-948
Number of pages6
JournalNutrition
Volume27
Issue number9
DOIs
Publication statusPublished - Sep 2011

Fingerprint

Soybean Proteins
Fatty Liver
Insulin Resistance
Diet
Liver
Fibrosis
Cholesterol
Lipids
Cytochrome P-450 CYP2E1
Lipid Peroxides
High Fat Diet
Catalase
Superoxide Dismutase
Sprague Dawley Rats
Adipose Tissue
Liver Diseases
Triglycerides

Keywords

  • Insulin resistance
  • Non-alcoholic fatty liver disease
  • Soy protein
  • Steatosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. / Yang, Hsin Yi; Tzeng, Ya Hui; Chai, Chiah Yang; Hsieh, An Tsz; Chen, Jiun-Rong; Chang, Le Shin; Yang, Sien Sing.

In: Nutrition, Vol. 27, No. 9, 09.2011, p. 943-948.

Research output: Contribution to journalArticle

Yang, Hsin Yi ; Tzeng, Ya Hui ; Chai, Chiah Yang ; Hsieh, An Tsz ; Chen, Jiun-Rong ; Chang, Le Shin ; Yang, Sien Sing. / Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. In: Nutrition. 2011 ; Vol. 27, No. 9. pp. 943-948.
@article{116869a6df8043da935336c5ac966db2,
title = "Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis",
abstract = "Objective: Non-alcoholic steatohepatitis (NASH) is a common cause of liver disease, and it may progress to fibrosis or cirrhosis. The aim of this study was to investigate the effects of soy protein on hepatic steatosis and insulin resistance in NASH. Methods: Forty male Sprague-Dawley rats were fed a high-fat diet for 4 wk to induce NASH and then were allocated to one of four diets: a NASH-inducing diet, a standard diet, a NASH-inducing diet plus soy protein, and a standard diet plus soy protein. Results: After the 10-wk experimental period, the results showed that soy protein significantly lowered plasma cholesterol concentrations and body fat accumulation. Soy protein intake also decreased the hepatic lipid depots of triacylglycerols and cholesterol and decreased the concentrations of lipid peroxides. In an analysis of antioxidative status, rats fed the soy protein diet showed improved antioxidative potential due to increases in superoxide dismutase and catalase activities and a decrease in the protein expression of cytochrome P450 2E1. Conclusion: Soy protein may improve the liver function in patients with NASH by lowering lipid levels in the blood and liver, increasing the antioxidative capacity, and improving insulin resistance.",
keywords = "Insulin resistance, Non-alcoholic fatty liver disease, Soy protein, Steatosis",
author = "Yang, {Hsin Yi} and Tzeng, {Ya Hui} and Chai, {Chiah Yang} and Hsieh, {An Tsz} and Jiun-Rong Chen and Chang, {Le Shin} and Yang, {Sien Sing}",
year = "2011",
month = "9",
doi = "10.1016/j.nut.2010.09.004",
language = "English",
volume = "27",
pages = "943--948",
journal = "Nutrition",
issn = "0899-9007",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis

AU - Yang, Hsin Yi

AU - Tzeng, Ya Hui

AU - Chai, Chiah Yang

AU - Hsieh, An Tsz

AU - Chen, Jiun-Rong

AU - Chang, Le Shin

AU - Yang, Sien Sing

PY - 2011/9

Y1 - 2011/9

N2 - Objective: Non-alcoholic steatohepatitis (NASH) is a common cause of liver disease, and it may progress to fibrosis or cirrhosis. The aim of this study was to investigate the effects of soy protein on hepatic steatosis and insulin resistance in NASH. Methods: Forty male Sprague-Dawley rats were fed a high-fat diet for 4 wk to induce NASH and then were allocated to one of four diets: a NASH-inducing diet, a standard diet, a NASH-inducing diet plus soy protein, and a standard diet plus soy protein. Results: After the 10-wk experimental period, the results showed that soy protein significantly lowered plasma cholesterol concentrations and body fat accumulation. Soy protein intake also decreased the hepatic lipid depots of triacylglycerols and cholesterol and decreased the concentrations of lipid peroxides. In an analysis of antioxidative status, rats fed the soy protein diet showed improved antioxidative potential due to increases in superoxide dismutase and catalase activities and a decrease in the protein expression of cytochrome P450 2E1. Conclusion: Soy protein may improve the liver function in patients with NASH by lowering lipid levels in the blood and liver, increasing the antioxidative capacity, and improving insulin resistance.

AB - Objective: Non-alcoholic steatohepatitis (NASH) is a common cause of liver disease, and it may progress to fibrosis or cirrhosis. The aim of this study was to investigate the effects of soy protein on hepatic steatosis and insulin resistance in NASH. Methods: Forty male Sprague-Dawley rats were fed a high-fat diet for 4 wk to induce NASH and then were allocated to one of four diets: a NASH-inducing diet, a standard diet, a NASH-inducing diet plus soy protein, and a standard diet plus soy protein. Results: After the 10-wk experimental period, the results showed that soy protein significantly lowered plasma cholesterol concentrations and body fat accumulation. Soy protein intake also decreased the hepatic lipid depots of triacylglycerols and cholesterol and decreased the concentrations of lipid peroxides. In an analysis of antioxidative status, rats fed the soy protein diet showed improved antioxidative potential due to increases in superoxide dismutase and catalase activities and a decrease in the protein expression of cytochrome P450 2E1. Conclusion: Soy protein may improve the liver function in patients with NASH by lowering lipid levels in the blood and liver, increasing the antioxidative capacity, and improving insulin resistance.

KW - Insulin resistance

KW - Non-alcoholic fatty liver disease

KW - Soy protein

KW - Steatosis

UR - http://www.scopus.com/inward/record.url?scp=79960960796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960960796&partnerID=8YFLogxK

U2 - 10.1016/j.nut.2010.09.004

DO - 10.1016/j.nut.2010.09.004

M3 - Article

C2 - 21333494

AN - SCOPUS:79960960796

VL - 27

SP - 943

EP - 948

JO - Nutrition

JF - Nutrition

SN - 0899-9007

IS - 9

ER -